Impact of serum amyloid A on high density lipoprotein composition and levels

Journal of Lipid Research

Volumn 51, Issue 11, 2010, Pages 3117-3125

  De Beer, Maria C ^a   Webb, Nancy R ^a   Wroblewski, Joanne M ^a   Noffsinger, Victoria P ^a   Rateri, Debra L ^a   Ji, Ailing ^a   Van Der Westhuyzen, Deneys R ^a,b   De Beer, Frederick C ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b LEXINGTON VA MEDICAL CENTER   (United States)

Author keywords

Acute phase; Apolipoprotein A I; High density lipoprotein characterization; Inflammation; Serum amyloid A deficient mice

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPOLYSACCHARIDE; PHOSPHOLIPID; SERUM AMYLOID A;

ARTICLE; CONTROLLED STUDY; GENE DELETION; INFLAMMATION; KNOCKOUT MOUSE; LIPID ANALYSIS; LIPID COMPOSITION; LIVER LEVEL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; STEADY STATE; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

ANIMALS; APOLIPOPROTEIN A-I; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; LIPOPROTEINS, HDL; LIVER; MALE; MICE; SERUM AMYLOID A PROTEIN;

EID: 78149303617     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M005413     Document Type: Article

References (26)

1. Chung, C. P., A. Oeser, P. Raggi, T. Gebretsadik, A. K. Shintani, T. Sokka, T. Pincus, I. Avalos, and C. M. Stein. 2005. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 52: 3045-3053.
2. Khovidhunkit, W., M. S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld. 2004. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 45: 1169-1196. (Pubitemid 38802622)
3. Coetzee, G. A., A. F. Strachan, D. R. van der Westhuyzen, H. C. Hoppe, M. S. Jeenah, and F. C. de Beer. 1986. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J. Biol. Chem. 261: 9644-9651.
4. de Beer, M. C., F. C. de Beer, C. J. Gerardot, D. R. Cecil, N. R. Webb, M. L. Goodson, and M. S. Kindy. 1996. Structure of the mouse Saa4 gene and its linkage to the serum amyloid A gene family. Genomics. 34: 139-142.
5. Sipe, J. D. 2000. Serum amyloid A: from fibril to function. Current status. Amyloid. 7: 10-12.
6. Whitehead, A. S., M. C. de Beer, D. M. Steel, M. Rits, J. M. Lelias, W. S. Lane, and F. C. de Beer. 1992. Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J. Biol. Chem. 267: 3862-3867.
7. Chiba, T., C. Y. Han, T. Vaisar, K. Shimokado, A. Kargi, M. H. Chen, S. Wang, T. O. McDonald, K. D. O'Brien, J. W. Heinecke, et al. 2009. Serum amyloid A3 does not contribute to circulating SAA levels. J. Lipid Res. 50: 1353-1362.
8. van der Westhuyzen, D. R., F. C. de Beer, and N. R. Webb. 2007. HDL cholesterol transport during inflammation. Curr. Opin. Lipidol. 18: 147-151.
9. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
10. Gowri, M. S., D. R. Van der Westhuyzen, S. R. Bridges, and J. W. Anderson. 1999. Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may be due to the abnormal composition of HDL. Arterioscler. Thromb. Vasc. Biol. 19: 2226-2233.
11. Bilheimer, D. W., S. Eisenberg, and R. I. Levy. 1972. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim. Biophys. Acta. 260: 212-221.
12. de Beer, M. C., F. C. de Beer, W. D. McCubbin, C. M. Kay, and M. S. Kindy. 1993. Structural prerequisites for serum amyloid A fibril formation. J. Biol. Chem. 268: 20606-20612.
13. Strachan, A. F., E. G. Shephard, D. U. Bellstedt, G. A. Coetzee, D. R. van der Westhuyzen, and F. C. de Beer. 1989. Human serum amyloid A protein. Behaviour in aqueous and urea-containing solutions and antibody production. Biochem. J. 263: 365-370.
14. Jahangiri, A., M. C. de Beer, V. Noffsinger, L. R. Tannock, C. Ramaiah, N. R. Webb, D. R. van der Westhuyzen, and F. C. de Beer. 2009. HDL remodeling during the acute phase response. Arterioscler. Thromb. Vasc. Biol. 29: 261-267.
15. Rashid, S., D. K. Trinh, K. D. Uffelman, J. S. Cohn, D. J. Rader, and G. F. Lewis. 2003. Expression of human hepatic lipase in the rabbit model preferentially enhances the clearance of triglyceride-enriched versus native high-density lipoprotein apolipoprotein A-I. Circulation. 107: 3066-3072.
16. Butler, A., and A. S. Whitehead. 1996. Mapping of the mouse serum amyloid A gene cluster by long-range polymerase chain reaction. Immunogenetics. 44: 468-474.
17. Cabana, V. G., J. R. Lukens, K. S. Rice, T. J. Hawkins, and G. S. Getz. 1996. HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL a factor in its decrease. J. Lipid Res. 37: 2662-2674.
18. Li, L., P. A. Thompson, and R. L. Kitchens. 2008. Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors. J. Lipid Res. 49: 1782-1793.
19. Feingold, K. R., I. Hardardottir, R. Memon, E. J. Krul, A. H. Moser, J. M. Taylor, and C. Grunfeld. 1993. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. J. Lipid Res. 34: 2147-2158.
20. McGillicuddy, F. C., M. de la Llera Moya, C. C. Hinkle, M. R. Joshi, E. H. Chiquoine, J. T. Billheimer, G. H. Rothblat, and M. P. Reilly. 2009. Inflammation impairs reverse cholesterol transport in vivo. Circulation. 119: 1135-1145.
21. de Beer, F. C., M. C. de Beer, D. R. van der Westhuyzen, L. W. Castellani, A. J. Lusis, M. E. Swanson, and D. S. Grass. 1997. Secretory non-pancreatic phospholipase A2: influence on lipoprotein metabolism. J. Lipid Res. 38: 2232-2239.
22. Kennedy, B. P., P. Payette, J. Mudgett, P. Vadas, W. Pruzanski, M. Kwan, C. Tang, D. E. Rancourt, and W. A. Cromlish. 1995. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J. Biol. Chem. 270: 22378-22385.
23. Hayek, T., T. Chajek-Shaul, A. Walsh, L. B. Agellon, P. Moulin, A. R. Tall, and J. L. Breslow. 1992. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels. J. Clin. Invest. 90: 505-510.
24. Bihl, F., L. Lariviere, S. T. Qureshi, L. Flaherty, and D. Malo. 2001. LPS-hyporesponsiveness of mnd mice is associated with a mutation in Toll-like receptor 4. Genes Immun. 2: 56-59. (Pubitemid 33674872)
25. Hosoai, H., N. R. Webb, J. M. Glick, U. J. Tietge, M. S. Purdom, F. C. de Beer, and D. J. Rader. 1999. Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice. J. Lipid Res. 40: 648-653.
26. Turnell, W., R. Sarra, I. D. Glover, J. O. Baum, D. Caspi, M. L. Baltz, and M. B. Pepys. 1986. Secondary structure prediction of human SAA1. Presumptive identification of calcium and lipid binding sites. Mol. Biol. Med. 3: 387-407.